Skip to main content

Table 3 Comparison of endpoint events incidence between high-Lp(a) and low-Lp(a) group

From: The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels

Endpoint events

Low-Lp(a) (n = 365)

High-Lp(a) (n = 151)

P

Major adverse cardiovascular events

68 (18.63)

46 (30.46)

0.003

 Cardiogenic death

7 (1.92)

4 (2.65)

0.633

 Non-fatal MI or ischemic stroke

15 (4.11)

10 (6.62)

0.226

 Hospitalization related to UA

26 (7.12)

20 (13.25)

0.026

 Unplanned coronary revascularization

46 (12.60)

33 (21.85)

0.008

Acute coronary events*

36 (9.86)

28 (18.54)

0.006

  1. *Acute coronary events included STEMI, NSTEMI and UA